Literature DB >> 16858168

Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial.

Ali Ahmed1, Wilbert S Aronow, Jerome L Fleg.   

Abstract

We performed a retrospective follow-up study of 1926 women with heart failure who participated in the Digitalis Investigation Group trial. Adjusted hazard ratios and 95% confidence intervals for covariates that were significant independent predictors of all-cause mortality were age in years (1.02; 1.01-1.03; P<0.001), NYHA class IH-IV (1.56; 1.31-1.87), diabetes (1.63; 1.36-1.95), glomerular filtration rate in mL/min/1.73 m(2) (0.99; 0.98-4).996; P=0.001), pulmonary congestion by chest x-ray (1.57; 1.22-2.02), left ventricular ejection fraction (LVEF) (0.99; 0.98-0.993; P<0.001), and use of digoxin (1.20; 1.02-1.42). Covariates that were significant independent predictors of hospitalization due to worsening heart failure were: nonwhite race (1.28; 1.03-1.58), NYHA class III-IV (1.55; 1.30-1.84), diabetes (1.75; 1.47-2.09), glomerular filtration rate as mL/min/1.73 m(2) (0.99; 0.986-0.996; P<0.001), pulmonary congestion by chest x-ray (1.42; 1.12-1.81), and use of ACE inhibitors (0.67; 0.49-0.91). Longer duration of heart failure, higher NYHA classes, diabetes, chronic kidney disease, pulmonary congestion, and lower LVEF were significant independent predictors of all-cause mortality, all-cause hospitalization, and hospitalization for heart failure in women with heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 16858168      PMCID: PMC2745160          DOI: 10.1097/00045391-200607000-00009

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  42 in total

1.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

2.  Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction.

Authors:  W S Aronow; C Ahn; I Kronzon
Journal:  Am J Cardiol       Date:  2000-06-01       Impact factor: 2.778

3.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

4.  Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm.

Authors:  W S Aronow; C Ahn; I Kronzon
Journal:  Am J Cardiol       Date:  2001-01-15       Impact factor: 2.778

5.  Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).

Authors:  T Simon; M Mary-Krause; C Funck-Brentano; P Jaillon
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

6.  Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

Authors:  E L Knight; R J Glynn; K M McIntyre; H Mogun; J Avorn
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

7.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

8.  Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

Authors:  L Rydén; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; M Packer; P A Poole-Wilson
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

9.  Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites.

Authors:  W S Aronow; C Ahn; I Kronzon
Journal:  Am J Cardiol       Date:  1999-09-01       Impact factor: 2.778

10.  Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure.

Authors:  Ali Ahmed; Jeffrey M Roseman; Andrew S Duxbury; Richard M Allman; James F DeLong
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

View more
  3 in total

Review 1.  Progress in heart failure treatment in Germany.

Authors:  Mark Luedde; Martina E Spehlmann; Norbert Frey
Journal:  Clin Res Cardiol       Date:  2018-07-02       Impact factor: 5.460

2.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

Review 3.  Use of Inotropic Agents in Treatment of Systolic Heart Failure.

Authors:  Sohaib Tariq; Wilbert S Aronow
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.